re: Ann: HeartWare Announces Date for FDA Adv... Any further delay after the 25th should be met with an official complaint.Denial of trading approval is only benefiting one party and IMO is being used accordingly.Surely it must be time to disband this department.Investor confidence is almost zilch towards any submissions made for them to trial.
